Structured Stroke Management Improves Outcome at 6 Months

This study has been completed.

First Received: October 12, 2007 Last Updated: October 16, 2008 History of Changes

Sponsors and Collaborators:	Kantonsspital Baden 407 Doctors
Information provided by:	Kantonsspital Baden
ClinicalTrials.gov Identifier:	NCT00544622

Purpose

Background/Aim of the study: To further reduce the 6 months stroke morbidity and mortality in a high volume stroke hospital and to compare the results with national and international data. Methods: 204 consecutive stroke patients are analyzed in a prospective study in a single center teaching institution. The intervention consists of a structured therapeutic chain of 290 collaborating GPs, a standardised acute hospital proceeding overlapping with an early integrated neurovascular rehabilitation within the same institution. Primary endpoints include death and dependence at 6 months, secondary endpoints are the length of hospital stay (LOS) and the quantitative analysis of physical and psychosocial impairments. The data are directly compared with the same endpoints of the Swiss subgroup of the international stroke trial (IST).

Condition	Intervention
Stroke	Procedure: structured therapeutic chain of stroke treatment

MedlinePlus related topics: Rehabilitation

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Non-Randomized, Open Label, Single Group Assignment
Official Title:	Structured Stroke Management Improves Outcome at 6 Months

Further study details as provided by Kantonsspital Baden:

Primary Outcome Measures:

Mortality, dependence, psychoscial outcome
Mortality, dependence and psychosocial outcome [ Time Frame: 6 months endpoint ]

Study Start Date:	January 2002
Estimated Study Completion Date:	March 2003

Eligibility

Ages Eligible for Study:	20 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

An acute cerebrovascular event (ischemic stroke or intra-cerebral bleeding (ICB)) with the signs and symptoms of an acute stroke according to the World Health Organisation definition of acute stroke14 within the last 12 hours without the need or possibility of a neurosurgical intervention
No thrombolytic therapy within the first 3 hours (in order to allow the correct comparison with the Swiss cohort of the IST trial
The informed consent of the patient or, if not possible, of the relatives
Living at home before the event
Lack of participation in another trial.

Exclusion Criteria:

Thrombolytic therapy within the first 3 hours (in order to allow the correct comparison with the Swiss cohort of the IST trial
No informed consent of the patient or, if not possible, of the relatives
Not living at home before the event
Participation in another trial (26 patients were excluded because of TIA with full recovery within 24 hours after the event)

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00544622

Sponsors and Collaborators

Kantonsspital Baden

407 Doctors

Investigators

Study Chair:

Juerg H. Beer, MD

Department of Medicine

More Information

No publications provided

Study ID Numbers:	INR50
Study First Received:	October 12, 2007
Last Updated:	October 16, 2008
ClinicalTrials.gov Identifier:	NCT00544622 History of Changes
Health Authority:	Switzerland: Federal Office of Public Health

Keywords provided by Kantonsspital Baden:

Stroke treatment
Rehabilitation
Stroke chain
Stroke unit

Study placed in the following topic categories:

Cerebral Infarction
Stroke
Vascular Diseases
Brain Ischemia
Central Nervous System Diseases

Ischemia
Brain Infarction
Brain Diseases
Infarction
Cerebrovascular Disorders

Additional relevant MeSH terms:

Cerebral Infarction
Nervous System Diseases
Stroke
Vascular Diseases
Brain Ischemia

Central Nervous System Diseases
Cardiovascular Diseases
Brain Infarction
Brain Diseases
Cerebrovascular Disorders

ClinicalTrials.gov processed this record on May 06, 2009